Champions Oncology公布了2024财年第二季度财报,财务状况显著改善,超出盈利预期,推动股价在盘后交易中大幅上涨。公司报告每股收益 (EPS)为0.05美元,远超预期亏损0.03美元。营收达到1350万美元,略高于预期的1332万美元。受此影响,该股在盘后交易中上涨10.15%,反映出投资者的乐观情绪。
JERUSALEM, Dec. 10 (Xinhua) -- Israeli Prime Minister Benjamin Netanyahu testified for the first time on Tuesday in his long-running corruption trial, marking a pivotal moment in the case as he ...